Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

The Phase 4 ENABLE study is set to be first in the U.S. to collect real-world safety and efficacy data of Briumvi for ...

HIGHER lesion burden in the uncinate fasciculus (UF), a key brain pathway linking emotional regulation regions, is associated with increased anxiety severity in multiple sclerosis (MS) patients, ...

This leads to lesions with localized inflammation, causing damage to the insulating sheath of nerve cells, known as myelin. As a result, individuals with MS may experience a wide range of ...

class drug evobrutinib reduced occurrence of central nervous system lesions in relapsing multiple sclerosis patients compared with placebo. Bruton’s kinase drugs are already used to treat ...